Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Center for Disease Control and Prevention (CDC) highlights importance of rapid chlamydia testing

This article was originally published in Clinica

Executive Summary

Rapid, non-laboratory chlamydia tests are a key tool in the Centers for Disease Control and Prevention's (CDC) war on STDs. CDC's director of STD prevention, Dr Judith Wasserheit, says "Three of the four long-term or irreversible complications that make sexually transmitted diseases a central public health priority are caused by chlamydia." The CDC believes immediate diagnosis and treatment with single-dose antibiotics could cut transmission.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094173

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel